Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine

ACS Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: 16(4), P. 520 - 522

Published: March 6, 2025

Recent advancements in psychedelic therapeutics, tryptamine derivatives, neuroplastic modulators, and AI-powered machine-learning platforms mark a new frontier precision medicine. These innovations address critical challenges neurological psychiatric disorders, chronic pain management, computational accessibility. By harnessing the principles of receptor modulation, targeted delivery systems, simplified AI integration, these breakthroughs promise transformative solutions for patient care technological development.

Language: Английский

---

Innovative Approaches in Psychedelics, AI, and Communication: A Multi-Domain Perspective

ACS Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: 16(4), P. 514 - 516

Published: March 11, 2025

Emerging innovations across psychedelics, artificial intelligence (AI), and communication technologies are reshaping healthcare beyond. This Patent Highlight showcases advancement in sublingual delivery systems for asymmetric phenylethylamine compounds, AI-assisted positioning, multi-modal data fusion, respectively. These inventions address challenges like drug inefficiencies, mental health treatment gaps, precision communication, integrated diagnostics. Together, they demonstrate the transformative potential of cross-disciplinary technological advancements enhancing precision, accessibility, scalability their respective fields.

Language: Английский

---

Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies

ACS Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: unknown

Published: April 10, 2025

Language: Английский

---